103 related articles for article (PubMed ID: 7534459)
1. Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities.
Yamada N; Arai Y; Funayama K; Kadowaki S; Takahashi K; Umezu K
Arzneimittelforschung; 1995 Jan; 45(1):33-5. PubMed ID: 7534459
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: the elucidation of the mechanism.
Kamei C; Mio M; Izushi K; Yoshii N; Fujisawa K; Tasaka K
Immunopharmacol Immunotoxicol; 1991; 13(3):341-56. PubMed ID: 1719061
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic effects of terfenadine on immediate type hypersensitivity reactions.
Akagi M; Mio M; Miyoshi K; Tasaka K
Immunopharmacol Immunotoxicol; 1987; 9(2-3):257-79. PubMed ID: 2449487
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I
Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of histamine release from rat peritoneal mast cells by MY-1250, an active metabolite of Repirinast (MY-5116).
Takei M; Endo K; Takahashi K
Int Arch Allergy Appl Immunol; 1990; 93(2-3):237-41. PubMed ID: 1712003
[TBL] [Abstract][Full Text] [Related]
6. MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells.
Yamada N; Kadowaki S; Takahashi K; Umezu K
Biochem Pharmacol; 1992 Sep; 44(6):1211-3. PubMed ID: 1358073
[TBL] [Abstract][Full Text] [Related]
7. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells.
Takei M; Endo K; Takahashi K
Br J Pharmacol; 1992 Mar; 105(3):587-90. PubMed ID: 1378339
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds.
Tateson JE; Trist DG
Life Sci; 1976 Jan; 18(2):153-61. PubMed ID: 56695
[No Abstract] [Full Text] [Related]
10. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
Yamada N; Takahashi K; Endoh K; Arai Y
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983
[TBL] [Abstract][Full Text] [Related]
12. Effects of thiazinamium chloride on histamine release from rat peritoneal mast cells and on phosphodiesterase activity in guinea pig lung.
Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
Int Arch Allergy Appl Immunol; 1986; 81(4):348-50. PubMed ID: 2430893
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
Frossard N; Landry Y; Pauli G; Ruckstuhl M
Br J Pharmacol; 1981 Aug; 73(4):933-8. PubMed ID: 6168323
[TBL] [Abstract][Full Text] [Related]
14. The effect of chopped rat lung on the inhibitory actions of prostaglandins, isoprenaline, theophylline and disodium cromoglycate on mast cell degranulation.
Taylor WA; Sheldon D
Monogr Allergy; 1977; 12():159-63. PubMed ID: 411025
[TBL] [Abstract][Full Text] [Related]
15. [Effects of MY-5116 on PCA reaction and on the histamine release from peritoneal cells induced by antigen antibody reactions].
Takahashi K; Shono T
Nihon Yakurigaku Zasshi; 1986 Jan; 87(1):29-39. PubMed ID: 2420688
[TBL] [Abstract][Full Text] [Related]
16. Adenosine activating A(2A)-receptors coupled to adenylate cyclase/cyclic AMP pathway downregulates nicotinic autoreceptor function at the rat myenteric nerve terminals.
Duarte-Araújo M; Timóteo MA; Correia-de-Sá P
Neurochem Int; 2004 Oct; 45(5):641-51. PubMed ID: 15234106
[TBL] [Abstract][Full Text] [Related]
17. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
19. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats.
Yanagihara Y; Kasai H; Shida T
Jpn J Pharmacol; 1988 Sep; 48(1):103-12. PubMed ID: 2462073
[TBL] [Abstract][Full Text] [Related]
20. Reduction in basal adenylate cyclase activity during the immunologic release of histamine from guinea pig lung.
Hitchcock M
J Immunol; 1977 Feb; 118(2):578-83. PubMed ID: 65429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
